Alan Smith, is currently the Executive Vice President Technical Operations at Bellicum Pharmaceuticals. He has broad experience in the cell therapy area with over 30 years working in various senior management roles in research and development, manufacturing and quality in cell and gene therapy companies. Prior to joining Bellicum, Dr. Smith held senior management positions at LifeNet Health, Cognate BioServices, Aastrom Biosciences, Geneic Sciences, Baxter Healthcare, BioSpecific Technologies and HyClone also as President of his own consulting company in the industry. Dr. Smith earned his BS degree in Chemistry at Southern Utah University and his doctorate in Biochemistry at Utah State University.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.